Role of P2X7 purinoceptors in neuroprotective mechanism of ischemic postconditioning in mice

Molecular and Cellular Biochemistry

Volumn 390, Issue 1-2, 2014, Pages 161-173

  Bindra, Chanpreet Singh ^a   Jaggi, Amteshwar Singh ^a   Singh, Nirmal ^a  

^a PUNJABI UNIVERSITY   (India)

Author keywords

Brilliant Blue G; Cerebral Ischemia; Ischemia reperfusion injury; Ischemic postconditioning; Neuroprotection in mice; Purinergic P2X7 receptor

Indexed keywords

NEUROPROTECTIVE AGENT; PURINERGIC P2X7 RECEPTOR;

ANIMAL; BRAIN ISCHEMIA; ISCHEMIC POSTCONDITIONING; ISCHEMIC PRECONDITIONING; MEMORY; METABOLISM; MOTOR CORTEX; MOUSE; PATHOLOGY; PHYSIOLOGY; REPERFUSION INJURY;

ANIMALS; BRAIN ISCHEMIA; ISCHEMIC POSTCONDITIONING; ISCHEMIC PRECONDITIONING; MEMORY; MICE; MOTOR CORTEX; NEUROPROTECTIVE AGENTS; RECEPTORS, PURINERGIC P2X7; REPERFUSION INJURY;

EID: 84898877148     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-014-1967-9     Document Type: Article

References (73)

1. 2+ exchanger inhibitor in mice. Biol Pharm Bull 33:585-591
2. World Health Organisation, WHO (2005) Preventing Chronic Diseases: a vital investment. WHO, Geneva
3. World Health Organisation, WHO (2010) Stroke, Cerebrovascular accident. WHO, Geneva
4. Mathers CD, Boerma T, Ma Fat D (2009) Global and regional causes of death. Br Med Bull 92:7-32
5. Wang L, Lu Y, Deng S, Zhang Y, Yang L, Guan Y, Matozaki T, Ohnishi H, Jiang H, Li H (2012) SHPS-1 deficiency induces robust neuroprotection against experimental stroke by attenuating oxidative stress. J Neurochem 122(4):834-843
6. Fairbanks SL, Brambrink AM (2010) Preconditioning and postconditioning for neuroprotection: the most recent evidence. Best Pract Res Clin Anaesthesiol 24(4):521-534
7. World Health Organisation, WHO (2009) Workshop report on stroke surveillance in India. WHO, Geneva
8. Murry CE, Jennings RB, Reimer KA (1986) Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74:1124-1136
9. Kitagawa K, Matsumoto M, Tagaya M, Hata R, Ueda H, Niinobe M, Handa N, Fukunaga R, Kimura K, Mikoshiba K (1990) 'Ischemic tolerance' phenomenon found in the brain. Brain Res 528:21-24
10. Zhao ZQ, Corvera JS, Halkos ME, Kerendi F, Wang NP, Guyton RA, Vinten-Johansen J (2003) Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol 285(2):H579-H588
11. Rehni AK, Singh N (2007) Role of phosphoinositide 3-kinase in ischemic postconditioning-induced attenuation of cerebral ischemia-evoked behavioral deficits in mice. Pharmacol Rep 59:192-198
12. Hausenloy DJ, Yellon DM (2011) The therapeutic potential of ischemic conditioning: an update. Nat Rev Cardiol 8(11):619-629
13. Zheng Z, Yang M, Zhang F, Yu J, Wang J, Ma L, Zhang Y, Qiau L, Chave G, Yu L, Yan M (2011) Gender-related difference of sevoflurane postconditioning in isolated rat hearts: focus on phosphatidylinositol-3-kinase/Akt signaling. J Surg Res 170(1):e3-e9
14. Liu X, Chen H, Zhan B, Xing B, Zhou J, Zhu H, Chen Z (2007) Attenuation of reperfusion injury by renal ischemic postconditioning: the role of NO. Biochem Biophys Res Commun 359:628-634
15. Kaur S, Jaggi AS, Singh N (2009) Molecular aspects of ischemic postconditioning. Fundam Clin Pharmacol 23:521-536
16. Rehni AK, Singh N, Jaggi AS, Singh M (2007) Amniotic fluid derived stem cells ameliorate focal cerebral ischemia-reperfusion injury induced behavioral deficits in mice. Behav Brain Res 183:95-100
17. Xi L, Das A, Zhao ZQ, Merino VF, Bader M, Kukreja RC (2008) Loss of myocardial ischemic postconditioning in adenosine A1 and bradykinin B2 receptors gene knockout mice. Circulation 118(14 Suppl):S32-S37
18. Wang J, Gao Q, Shen J, Ye TM, Xia Q (2007) Kappa-opioid receptor mediates the cardioprotective effect of ischemic postconditioning. Zhejiang Da Xue Xue Bao Xi Xue Ban 36:41-47
19. Hausenloy DJ, Yellon DM (2006) Survival kinases in ischemic preconditioning and postconditioning. Cardiovasc Res 70:240-253
20. Vinten-Johansen J (2007) Postconditioning a mechanical maneuver that triggers biological and molecular cardioprotective responses to reperfusion. Heart Fail Rev 12:235-244
21. Zatta AJ, Kin H, Lee G, Wang N, Jiang R, Lust R, Reeves JG, Mykytenko J, Guyton RA, Zhao ZQ, Vinten-Johansen J (2006) Infarct sparing effect of myocardial postconditioning is dependent on protein kinase C signalling. Cardiovasc Res 70:315-324
22. Namiuchi S, Kagaya Y, Ohta J, Shiba N, Sugi M, Oikawa M, Kunii H, Yamao H, Komatsu N, Xui M, Tada M, Sakuma M, Watanabe J, Ichihara T, Shirato K (2005) High serum erythropoietin level is associated with smaller infarct size in patients with acute myocardial infarction who undergo successful primary percutaneous coronary intervention. J Am Coll Cardiol 45:1406-1412
23. Feng C, Luo T, Qi L, Wang B, Luo Y, Ge P (2012) Ischemic postconditioning alleviates neuronal injury caused by relief of carotid stenosis in a rat model of cerebral hypoperfusion. Int J Mol Sci 13:13338-13351
24. Fan Q, Yang XC, Liu Y, Wang LF, Liu SH, Ge YG, Chen ML, Wang W, Zhang LK, Irwin MG, Xia Z (2011) Postconditioning attenuates myocardial injury by reducing nitro-oxidative stress in vivo in rats and in humans. Clin Sci 120:251-261
25. Tozaki-Saitoh H, Tsuda M, Inoue K (2011) Role of purinergic receptors in CNS function and neuroprotection. Adv Pharmacol 61:495-528
26. Burnstock G (1978) A basis for distinguishing two types of purinergic receptor. In: Straub RW, Bolis L (eds) Cell membrane receptors for drugs and hormones: a multidisciplinary approach. Raven Press, New York, pp 107-118
27. Ralevic V, Burnstock G (1998) Receptors for purines and pyrimidines. Pharmacol Rev 50:413-492
28. Abbracchio MP, Burnstock G (1994) Purinoceptors: there are families of P2X and P2Y purinoceptors. Pharmacol Ther 64:445-475
29. Burnstock G, Kennedy C (1985) Is there a basis for distinguishing two types of P2-purinoceptor? Gen Pharmacol 16:433-440
30. Abbracchio MP, Burnstock G, Boeynaems JM, Barnard EA, Boyer JL, Kennedy C, Knight GE, Fumagalli M, Gachet C, Jacobson KA, Weisman GA (2006) International Union of Pharmacology. Update and subclassification of the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy. Pharmacol Rev 58:281-341
31. Burnstock G (2007) Physiology and pathophysiology of Purinergic Neurotransmission. Physiol Rev 87:659-797
32. Shabbir M, Burnstock G (2009) Purinergic receptor mediated effects of adenosine 5′-triphosphate in urological malignant diseases. Int J Urol 16:143-150
33. Vessey DA, Li L, Kelley M (2011) P2X7 receptor agonists pre- and postcondition the heart against ischemia-reperfusion injury by opening pannexin-1/P2X7 channels. Am J Physiol Heart Circ Physiol 301:H881-H887
34. Wang Z, Liu T, Gan L, Wang T, Yuan X, Zhang B, Chen H, Zheng Q (2010) Shikonin protects mouse brain against cerebral ischemia/reperfusion injury through its antioxidant activity. Eur J Pharmacol 643(2-3):211-217
35. Kallman MJ, Kaempf GL, Balster RL (1948) Behavioral toxicity of chloral in mice: an approach to evaluation. Neurobehav Toxicol Teratol 6:137-146
36. Himori N, Wantanabe H, Akaike N, Kurasawa M, ltoh J, Tanaka Y (1990) Cerebral ischemia model with conscious mice. Involvement of NMDA receptor activation and derangement of learning and memory ability. J Pharmacol Method 23:311-327
37. Rehni AK, Singh N, Jaggi AS (2007) Possible involvement of insulin, endogenous opioids and calcitonin gene related peptide in remote ischemic preconditioning of brain. Yakugaku zasshi 127:1020-1030
38. Bochelen D, Rudin M, Sauter A (1999) Calcineurin inhibitors FK506 and SDZ ASM 981 alleviate the outcome of focal cerebral ischemic/reperfusion injury. J Pharmacol Exp Ther 288:653-659
39. Joshi CN, Jain SK, Murthy PS (2004) An optimized triphenyltetrazolium chloride method for identification of cerebral infarcts. Brain Res Protoc 13:11-17
40. Türeyen K, Vemuganti R, Sailor KA, Dempsey RJ (2004) Infarct volume quantification in mouse focal cerebral ischemia: a comparison of triphenyltetrazolium chloride and cresyl violet staining techniques. J Neurosci Methods 139:203-207
41. Morris RG (1984) Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods 11:47-60
42. Parle M, Singh N (2004) Animal models for testing memory. Asia Pac J Pharmacol 16:101-102
43. Dunham NW, Miya TS (1957) A note on a simple apparatus for detecting neurological deficit in rats and mice. J Am Pharm Assoc (Baltim) 46:208-209
44. Feeney DM, Boyeson MG, Linn RT, Murray HM, Dail WG (1981) Responses to cortical injury: I. Methodology and local effects of contusions in the rat. Brain Res 211:67-77
45. Chen Y, Constantini S, Trembovler V, Weinstock M, Shohami E (1996) An experimental model of closed head injury in mice: pathophysiology, histopathology, and cognitive deficits. J Neurotrauma 13:557-568
46. Schallert T, Kozlowski DA, Humm JL, Cocke RR (1997) Use-dependent structural events in recovery of function. Adv Neurol 73:229-238
47. Ellman GL, Courtney KD, Valentino A, Featherstone RM (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7:88-95
48. Ohkawa H, Ohishi N, Yagi K (1979) Assay of lipid peroxides in animals tissue by thiobarbituraic acid reaction. Anal Biochem 95:351-358
49. Beutler RG, Duron O, Kelly B (1963) Reduced glutathion estimation. J Lab Clin Med 61:82
50. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with folin phenol reagent. J Biol Chem 193:265-275
51. Alonso de Lecinana M, Diez-Tejedor E, Cearcellar F, Roda JM (2001) Cerebral ischemia: from animal studies to clinical practice. Should the methods be reviewed? Cerebrovasc Dis 11:20-30
52. Jenkins LW, Povlishock JT, Lewelt W, Miller JD, Becker DP (1981) The role of postischemic recirculation in the development of ischemic neuronal injury following complete cerebral ischemia. Acta Neuropathol 55:205-220
53. Dobkin BH (1991) The rehabilitation of elderly stroke patients. Clin Geriatr Med 7:507-523
54. Rehni AK, Bhateja P, Singh N, Jaggi AS (2008) Implication of mast cell degranulation in ischemic pre-conditioning induced prevention of cerebral injury. Fundam Clin Pharmacol 22:179-188
55. Gulati P, Muthuraman A, Jaggi AS, Singh N (2013) Neuroprotective effect of gadolinium: a stretch-activated calcium channel blocker in mouse model of ischemia-reperfusion injury. Naunyn-Schmiedeberg's Arch Pharmacol 386:255-264
56. Wong AM, Hodges H, Horsburgh K (2005) Neural stem cell grafts reduce the extent of neuronal damage in a mouse model of global Ischemia. Brain Res 1063:140-150
57. Dong W, Zhang Z, Liu Z, Liu H, Wang X, Bi S, Wang X, Ma T, Zhang W (2005) Protective effects of osthole, a natural derivative of coumarin, against intestinal ischemia-reperfusion injury in mice. Int J Mol Med 31:1367-1374
58. Haass C, Selkoe DJ (2007) Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide. Nat Rev Mol Cell Biol 8(2):101-112
59. Zhang W, Miao Y, Zhou S, Jiang J, Luo Q, Qiu Y (2011) Neuroprotective effects of ischemic postconditioning on global brain ischemia in rats through upregulation of hippocampal glutamine synthetase. J Clin Neurosci 18:685-689
60. Zhou C, Tu J, Zhang Q, Lu D, Zhu Y, Zhang W, Yang F, Brann DW, Wang R (2011) Delayed ischemic postconditioning protects hippocampal CA1 neurons by preserving mitochondrial integrity via Akt/GSK3β signaling. Neurochem Int 59(6):749-758
61. Boison D (2011) Modulators of Nucleoside Metabolism in the Therapy of brain diseases. Curr Top Med Chem 11(8):1068-1086
62. Varma H, Cheng R, Voisine C, Hart AC, Stockwell BR (2007) Inhibitors of metabolism rescue cell death in Huntington's disease models. Proc Natl Acad Sci USA 104(14):514-525, 530
63. Engel T, Gomez-Villafuertes R, Tanaka K, Mesuret G, Sanz-Rodriguez A, Garcia-Huerta P, Miras-Portugal MT, Henshall DC, Diaz-Hernandez M (2012) Seizure suppression and neuroprotection by targeting the purinergic P2X7 receptor during status epilepticus in mice. FASEB J 26(4):1616-1628
64. Clanet M (1825) "Jean-Martin Charcot. 1825 to 1893" (PDF). Int MS J 15(2):59-61
65. Chen J, Wang L, Zhang Y, Yang J (2012) P2Y1 purinoceptor inhibition reduces extracellular signal-regulated protein kinase 1/2 phosphorylation in spinal cord and dorsal root ganglia: implications for cancer-induced bone pain. Acta Biochem Biophys Sin 44:367-372
66. Li N, Hu L, Wang L, Wang G, Wang D, Jin L, Sun B, Li H (2012) Activation of the adenosine A2A receptor attenuates experimental autoimmune myasthenia gravis severity. Eur J Immunol 42:1140-1151
67. Gulbransen BD, Bashashati M, Hirota SA, Gui X, Roberts JA, MacDonald JA, Muruve DA, McKay DM, Beck PL, Mawe GM, Thompson RJ, Sharkey KA (2012) Activation of neuronal P2X7 receptor-pannexin-1 mediates death of enteric neurons during colitis. Nat Med 18(4):600-604
68. Filip M, Zaniewska M, Frankowska M, Wydra K, Fuxe K (2012) The importance of the Adenosine A(2A) receptor-Dopamine D(2) receptor interaction in drug addiction. Curr Med Chem 19(3):317-355
69. Huang ZL, Urade Y, Hayaishi O (2007) Prostaglandins and adenosine in the regulation of sleep and wakefulness. Curr Opin Pharmacol 7(1):33-38
70. Puthussery T, Fletcher EL (2009) Extracellular ATP induces retinal photoreceptor apoptosis through activation of purinoceptors in rodents. J Comp Neurol 513:430-440
71. Hocher B, Heiden S, Websky KV, Arafat AM, Rahnenfuhrer J, Alter M, Klk P, Ziegler D, Fischer Y, Pfab T (2011) Renal Effects of the Novel Selective Adenosine A1 receptor blocker SLV329 in experimental liver Cirrhosis in rats. PLoS ONE 6(3):e17891
72. Vessey DA, Li L, Kelley M (2010) Pannexin-1/P2X7 purinergic receptor channels mediate the release of cardioprotectants induced by ischemic pre- and postconditioning. J Cardiovasc Pharmacol Ther 15:190-195
73. Surprenant A, North RA (2009) Signaling at purinergic P2X receptors. Annu Rev Physiol 71:333-359